P. A. Rascoe, D. Jupiter, X. Cao, J. E. Littlejohn, and W. R. Smythe, Molecular pathogenesis of malignant mesothelioma, Expert Rev Mol Med, vol.14, p.12, 2012.

S. X. Huang, M. C. Jaurand, D. W. Kamp, J. Whysner, and T. K. Hei, Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases, J Toxicol Environ Health B Crit Rev, vol.14, issue.1-4, pp.179-245, 2011.

D. W. Kamp, Asbestos-induced lung diseases: an update, Transl Res, vol.153, issue.4, pp.143-152, 2009.

J. C. Pairon, F. Laurent, M. Rinaldo, B. Clin, P. Andujar et al., Pleural plaques and the risk of pleural mesothelioma, J Natl Cancer Inst, vol.105, issue.4, pp.293-301, 2013.

M. Carbone, Y. I. Baris, P. Bertino, B. Brass, S. Cornertpay et al., Erionite exposure in North Dakota and Turkish villages with mesothelioma, Proc Natl Acad Sci, p.108, 2011.

A. Lacourt, C. Gramond, S. Audignon, S. Ducamp, J. Fevotte et al., Pleural Mesothelioma and Occupational Co-exposure to Asbestos, Mineral Wool and Silica, Am J Respir Crit Care Med, 2013.

J. Pintos, M. E. Parent, B. W. Case, M. C. Rousseau, and J. Siemiatycki, Risk of mesothelioma and occupational exposure to asbestos and man-made vitreous fibers: evidence from two case-control studies in Montreal, Canada, J Occup Environ Med, vol.51, issue.10, pp.1177-1184, 2009.

M. C. Jaurand, A. Renier, and J. Daubriac, Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk?, Part Fibre Toxicol, vol.6, pp.16-29, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00387933

B. Jasani and A. Gibbs, Mesothelioma not associated with asbestos exposure, Arch Pathol Lab Med, vol.2012, issue.3, pp.262-267

H. Gibb, K. Fulcher, S. Nagarajan, S. Mccord, N. A. Fallahian et al., Analyses of Radiation and Mesothelioma in the US Transuranium and Uranium Registries, Am J Public Health, vol.103, issue.4, pp.710-716, 2013.

M. Neri, R. Filiberti, E. Taioli, S. Garte, V. Paracchini et al., Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure, Mutat Res, 2005.

V. C. Broaddus, J. I. Everitt, B. Black, and A. B. Kane, Non-neoplastic and neoplastic pleural endpoints following fiber exposure, J Toxicol Environ Health B Crit Rev, vol.14, issue.1-4, pp.153-178, 2011.

A. Shukla, M. Ramos-nino, and B. Mossman, Cell signaling and transcription factor activation by asbestos in lung injury and disease, Intl J Biochem Cell Biol, vol.35, pp.1198-1209, 2003.

C. Dostert, V. Petrilli, R. Van-bruggen, C. Steele, B. T. Mossman et al., Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica, Science, vol.320, issue.5876, pp.674-677, 2008.

M. T. Chow, J. Tschopp, A. Moller, and M. J. Smyth, NLRP3 promotes inflammation-induced skin cancer but is dispensable for asbestos-induced mesothelioma, Immunol Cell Biol, vol.90, issue.10, pp.983-986, 2012.

B. Cortez, G. Quassollo, A. Caceres, and G. M. Machado-santelli, The fate of chrysotileinduced multipolar mitosis and aneuploid population in cultured lung cancer cells, PLoS ONE, vol.6, issue.4, p.18600, 2011.

M. Carbone, B. H. Ly, R. F. Dodson, I. Pagano, P. T. Morris et al., Malignant mesothelioma: facts, myths, and hypotheses, J Cell Physiol, vol.2012, issue.1, pp.44-58

H. Y. Dong, A. Buard, F. Levy, A. Renier, F. Laval et al., Synthesis of poly(ADPribose) in asbestos treated rat pleural mesothelial cells in culture, Mutat Res, vol.331, pp.197-204, 1995.

D. Upadhyay and D. W. Kamp, Asbestos-induced pulmonary toxicity: role of DNA damage and apoptosis, Exp Biol Med (Maywood), vol.228, issue.6, pp.650-659, 2003.

M. Tomasetti, M. Amati, L. Nocchi, F. Saccucci, E. Strafella et al., Asbestos exposure affects poly(ADP-ribose) polymerase-1 activity: role in asbestos-induced carcinogenesis, vol.26, pp.585-591, 2011.

A. Churg and F. Galateau-salle, The separation of benign and malignant mesothelial proliferations, Arch Pathol Lab Med, vol.2012, issue.10, pp.1217-1226

V. Relan, L. Morrison, K. Parsonson, B. E. Clarke, E. E. Duhig et al., Phenotypes and karyotypes of human malignant mesothelioma cell lines, PLoS One, vol.8, issue.3, p.58132, 2013.

S. Matsumoto, K. Nabeshima, T. Kamei, K. Hiroshima, K. Kawahara et al., Morphology of 9p21 homozygous deletionpositive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology, Cancer Cytopathol, 2013.

D. Jean, J. Daubriac, L. Pimpec-barthes, F. Galateau-salle, F. et al., Molecular changes in mesothelioma with an impact on prognosis and treatment, Arch Pathol Lab Med, vol.2012, issue.3, pp.277-293
URL : https://hal.archives-ouvertes.fr/inserm-02478588

A. Tallet, J. C. Nault, A. Renier, I. Hysi, F. Galateau-salle et al., Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma, Oncogene, vol.33, issue.28, pp.3748-3752, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02478602

V. Balatti, S. Maniero, M. Ferracin, A. Veronese, M. Negrini et al., MicroRNAs dysregulation in human malignant pleural mesothelioma, J Thorac Oncol, vol.6, issue.5, pp.844-851, 2011.

O. Melaiu, A. Cristaudo, E. Melissari, D. Russo, M. Bonotti et al., A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma, Mutat Res, vol.750, issue.2, pp.132-140, 2012.

G. Pinton, A. G. Manente, L. Moro, and L. Mutti, Circulating tumor cells as a diagnostic test for malignant pleural mesothelioma, Expert Opin Med Diagn, vol.6, issue.3, pp.171-173, 2013.

S. E. Mutsaers, Mesothelial cells: their structure, function and role in serosal repair, Respirology, vol.7, issue.3, pp.171-191, 2002.

F. I. Ghani, H. Yamazaki, S. Iwata, T. Okamoto, K. Aoe et al., Identification of cancer stem cell markers in human malignant mesothelioma cells, Biochem Biophys Res Commun, vol.404, issue.2, pp.735-742, 2011.

D. Hanahan and R. A. Weinberg, Hallmarks of cancer: the next generation, Cell, vol.2012, issue.5, pp.646-674

J. Fleury-feith, C. Lecomte, A. Renier, M. Matrat, L. Kheuang et al., Hemizygosity of N?2 is associated with increased susceptibility to asbestos-induced peritoneal tumours, Oncogene, vol.22, pp.3799-3805, 2003.

L. A. Loeb, Human cancers express mutator phenotypes: origin, consequences and targeting, Nat Rev Cancer, vol.11, issue.6, pp.450-457, 2011.

N. J. Ganem and D. Pellman, Linking abnormal mitosis to the acquisition of DNA damage, J Cell Biol, vol.2012, issue.6, pp.871-881